Natalizumab in secondary progressive multiple sclerosis

被引：3
|
作者：
Edan, Gilles [1 ]
机构：
[1] CHU Pontchaillou, INSERM, CIC1414, F-35033 Rennes, France
来源：
LANCET NEUROLOGY | 2018年 / 17卷 / 05期
关键词：
MS;
D O I：
10.1016/S1474-4422(18)30108-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：384 / 385
页数：2
相关论文
共 50 条
  • [1] Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis
    Sellebjerg, Finn
    Cadavid, Diego
    Steiner, Deborah
    Maria Villar, Luisa
    Reynolds, Richard
    Mikol, Daniel
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2016, 9 (01) : 31 - 43
  • [2] Quantifying clinical predictors of optimal response to natalizumab in secondary progressive multiple sclerosis
    Sargento-Freitas, J.
    Batista, S.
    Marques, I.
    Macario, C.
    Matias, F.
    Sousa, L.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S463 - S464
  • [3] Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis
    Alvarez-Cermeño, JC
    Masjuan, J
    Villar, LM
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (16): : 1744 - 1745
  • [4] The effect of natalizumab and interferon beta-1a on disability in secondary progressive multiple sclerosis
    Dzau, Winston
    Roos, Izanne
    Kalincik, Tomas
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1166 - 1167
  • [5] A potential role for continuation of natalizumab therapy in patients with secondary progressive multiple sclerosis.
    Yap, Siew Mei
    McNicholas, Nuala
    Tubridy, Niall
    Hutchinson, Michael
    McGuigan, Christopher
    NEUROLOGY, 2017, 88
  • [6] Efficacy of natalizumab in secondary progressive multiple sclerosis: analysis of two phase III trials
    Dzau, Winston
    Roos, Izanne
    Kalincik, Tomas
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2025,
  • [7] Progressive Multifocal Leukoencephalopathy with Natalizumab Treatment of Multiple Sclerosis
    Clifford, David B.
    DeLuca, Andrea
    Simpson, David
    Arendt, Gabriele
    Giovannoni, Gavin
    Nath, Avindra
    NEUROLOGY, 2010, 74 (09) : A281 - A282
  • [8] Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis - Reply
    Kleinschmidt-DeMasters, BK
    Tyler, KL
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (16): : 1745 - 1745
  • [9] Multiple sclerosis, natalizumab therapy, and progressive multifocal leukoencephalopathy
    Bartt, Russell E.
    CURRENT OPINION IN NEUROLOGY, 2006, 19 (04) : 341 - 349
  • [10] Risk of conversion to secondary progressive multiple sclerosis is not associated with relapse rate under natalizumab treatment
    Romero-Pinel, L.
    Matas, E.
    Bau, L.
    Leon, I.
    Mane-Martinez, M. A.
    Jato, M.
    Hernandez-Regadera, J. J.
    Martinez-Yelamos, A.
    Martinez-Yelamos, S.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 155 - 156
12345